Elaine Riddell

Elaine is a managing director at Oaklins DeSilva+Phillips in New York. She has deep operational expertise in the data, analytics and insights-led consulting industry supporting healthcare and, in particular, life sciences as well as consumer-driven sectors and on a global basis. Elaine brings an understanding of the disruptive market dynamics shaping these industries and influencing M&A priorities and spending. This highly relevant market knowledge has enabled Oaklins’ insights and healthcare teams to be invited to pitch and to win a majority of these new pitches. Prior to joining Oaklins DeSilva+Phillips in 2020, Elaine was a divisional CEO for 15 years at Kantar Health (now Oracle Cerner Enviza), TNS Healthcare (acquired by Kantar) and NOPWorld Health, a unit of UBM. She is recognized as an industry innovator who transforms mature, stagnant, global data, analytics and insights-led consulting firms into high-performing, scaled market leaders with sustained, profitable revenue growth at three times the market rate. Elaine draws on her experience at Abbott Labs (now AbbVie), a top 10 pharmaceutical company, and IMS Health (now IQVIA), the leading multinational health information and technology firm. This breadth of experience forms the foundation of her growth advisory serving founder/CEOs and private equity firms, and her contribution to M&A advisory and successful transactions.